Addyi rems training

addyi rems training

Certification program now available for health-care prescribers and pharmacies to prescribe or dispense Addyi ™ (flibanserin 100 mg) Sprout.
FDA News Release. FDA approves first treatment for sexual desire disorder. Addyi approved to treat premenopausal women.
Risk Evaluation and Mitigation Strategy (REMS) FDA REQUIRED REMS SAFETY INFORMATION This website is intended for US Healthcare Professionals Addyi REMS.

Addyi package insert fda

addyi package insert fda

87 rows  · Drug Active Ingredient Date of FDA Approval What is it Approved For.
The Food and Drug Administration Amendments Act of 2007 gave FDA the authority to require a Risk Evaluation and Mitigation Strategy (REMS) from manufacturers to.
FDA application and approval History for Addyi (flibanserin) supplied by Sprout Pharmaceuticals, Inc.